Long-Term Outcomes of a Phase I Study With UV1, a Second Generation Telomerase Based Vaccine, in Patients With Advanced Non-Small Cell Lung Cancer

by Paal F. Brunsvig, Tormod Kyrre Guren, Marta Nyakas, Claudius H. Steinfeldt-Reisse, Wenche Rasch, Jon Amund Kyte, Hedvig Vidarsdotter Juul, Steinar Aamdal, Gustav Gaudernack, Else Marit Inderberg
Published 2020-11-01

Combining a Universal Telomerase Based Cancer Vaccine With Ipilimumab in Patients With Metastatic Melanoma - Five-Year Follow Up of a Phase I/IIa Trial

by Elin Aamdal, Elin Aamdal, Elin Aamdal, Else Marit Inderberg, Espen Basmo Ellingsen, Espen Basmo Ellingsen, Espen Basmo Ellingsen, Wenche Rasch, Paal Fredrik Brunsvig, Steinar Aamdal, Steinar Aamdal, Steinar Aamdal, Karen-Marie Heintz, Daniel Vodák, Sigve Nakken, Sigve Nakken, Eivind Hovig, Eivind Hovig, Marta Nyakas, Marta Nyakas, Tormod Kyrre Guren, Gustav Gaudernack, Gustav Gaudernack
Published 2021-05-01